Products that can prove their efficacy in treating smoking addiction can pursue a medical licence route in the UK. The MHRA, Britain’s pharmaceutical regulator, is currently encouraging and supporting companies to submit medicines authorisation applications for e-cigarette products.
This route offers both advantages and disadvantages. Though quite costly and time-consuming, it enables producers and sellers to make health claims and sidestep product restrictions imposed on tobacco-related e-cigarette products.
This regulatory report from ECigIntelligence explains how the process works, and examines the pros and cons.
...
Need help?
Contact a sales representative right now and don’t wait
“ The medical route to market approval in the UK – the pros and cons ”
Buy report request information:
“ The medical route to market approval in the UK – the pros and cons ”
We also invite you to enjoy our FREE TRIAL
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.